Alzheimer s Disease (AD) has historically been a condition associated with more questions than answers. These questions are only increasing with the flurry of developmental activity in recent years, particularly the introduction of the first ever disease modifying therapies, as the clinical picture is dramatically changing each day. To help address rising challenges prompted by this shifting paradigm, this activity features real questions from practicing clinicians regarding the integration of and expert perspectives on amyloid-targeting therapies for the treatment of AD.
- Provider:Medical Education Resources
- Activity Link: https://reachmd.com/programs/cme/the-frontline-of-alzheimers-care-addressing-real-questions-from-clinicians-in-the-new-dawn-of-disease-modifying-therapy/16036/
- Start Date: 2024-01-31 06:00:00
- End Date: 2024-01-31 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.25 hours
- Commercial Support: Source: Lilly (Any division) - Amount: 0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence, Learner/Team Performance
- Provider Ship: Jointly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest